|
AU572125B2
(en)
*
|
1983-03-17 |
1988-05-05 |
Mabco Limited |
Monoclonal antibodies with specificity for crosslinked fibrin and their diagnotic uses
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US5047335A
(en)
|
1988-12-21 |
1991-09-10 |
The Regents Of The University Of Calif. |
Process for controlling intracellular glycosylation of proteins
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5278299A
(en)
|
1991-03-18 |
1994-01-11 |
Scripps Clinic And Research Foundation |
Method and composition for synthesizing sialylated glycosyl compounds
|
|
WO1993010260A1
(en)
|
1991-11-21 |
1993-05-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Controlling degradation of glycoprotein oligosaccharides by extracellular glycosisases
|
|
US5648267A
(en)
|
1992-11-13 |
1997-07-15 |
Idec Pharmaceuticals Corporation |
Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same
|
|
CU22615A1
(es)
|
1994-06-30 |
2000-02-10 |
Centro Inmunologia Molecular |
Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
|
|
DE69535243T2
(de)
|
1994-07-13 |
2007-05-10 |
Chugai Seiyaku K.K. |
Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper
|
|
US5986065A
(en)
*
|
1997-03-10 |
1999-11-16 |
Sunol Molecular Corporation |
Antibodies for inhibiting blood coagulation and methods of use thereof
|
|
DK1071700T3
(da)
|
1998-04-20 |
2010-06-07 |
Glycart Biotechnology Ag |
Glykosylerings-modifikation af antistoffer til forbedring af antistofafhængig cellulær cytotoksicitet
|
|
CA2953239A1
(en)
|
2000-10-06 |
2002-04-18 |
Kyowa Hakko Kirin Co., Ltd. |
Antibody composition-producing cell
|
|
US8372954B2
(en)
|
2000-12-22 |
2013-02-12 |
National Research Council Of Canada |
Phage display libraries of human VH fragments
|
|
IL161686A0
(en)
|
2001-11-01 |
2004-09-27 |
Uab Research Foundation |
Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
|
|
AU2003277832A1
(en)
*
|
2002-10-31 |
2004-05-25 |
Novo Nordisk A/S |
Humanized tissue factor antibodies
|
|
US20050031615A1
(en)
*
|
2003-05-30 |
2005-02-10 |
Anderson G. Mark |
Method of inhibiting tumor growth with anti-tissue factor antibodies
|
|
US8722044B2
(en)
*
|
2011-03-15 |
2014-05-13 |
Janssen Biotech, Inc. |
Human tissue factor antibody and uses thereof
|
|
ES2773710T3
(es)
|
2012-10-11 |
2020-07-14 |
Daiichi Sankyo Co Ltd |
Enlazadores para conjugados de anticuerpo - fármaco
|
|
MX2016009690A
(es)
|
2014-02-03 |
2017-03-03 |
Nat Cancer Ct |
Anticuerpos monoclonal anti-factor de tejido.
|
|
JP2017114763A
(ja)
*
|
2014-03-26 |
2017-06-29 |
第一三共株式会社 |
抗ｃｄ９８抗体−薬物コンジュゲート
|
|
EP3502141A4
(en)
*
|
2016-08-22 |
2020-04-08 |
Fudan University |
ANTIBODIES TAKEN AGAINST THE TISSUE FACTOR, MANUFACTURING METHODS THEREFOR AND USE THEREOF
|
|
TW201922796A
(zh)
*
|
2017-10-30 |
2019-06-16 |
國立研究開發法人國立癌症研究中心 |
可用於實體腫瘤治療之抗體及其抗體－藥物共軛物以及含其之抗癌劑
|
|
CN111727075B
(zh)
*
|
2017-11-27 |
2024-04-05 |
普渡制药公司 |
靶向人组织因子的人源化抗体
|
|
MX2020007077A
(es)
*
|
2018-01-04 |
2020-10-28 |
Iconic Therapeutics Inc |
Anticuerpos anti-factor tisular, conjugados anticuerpo-farmaco y metodos relacionados.
|
|
CA3108044A1
(en)
*
|
2018-07-31 |
2020-02-06 |
Daiichi Sankyo Company, Limited |
Treatment of metastatic brain tumor by administration of antibody-drug conjugate
|
|
EA202190471A1
(ru)
*
|
2018-08-06 |
2021-05-24 |
Дайити Санкио Компани, Лимитед |
Комбинация конъюгата антитела-лекарственного средства и ингибитора тубулина
|
|
MX2021001058A
(es)
*
|
2018-08-16 |
2021-04-12 |
Genmab As |
Conjugados de anticuerpo anti-factor tisular-farmaco y su uso en el tratamiento de un cancer.
|